Cost-Effectiveness Studies Too Diverse To Inform CMS Policy, Report Finds
This article was originally published in The Gray Sheet
Executive Summary
A report finds that the methodologies used in published cost-effectiveness studies are too diverse to inform Medicare policy-making, but that the literature could be useful in singling out therapies for a closer look
You may also be interested in...
MedPAC Report Explores Ways For CMS To Use Cost-Effectiveness Analysis
CMS could select certain expensive medical devices, surgical and diagnostic procedures for government-sponsored cost-effectiveness research, according to MedPAC's June report to Congress
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.